Martin Shkreli on AI, Pharma, and What Actually Matters
About this episode
Erik Torenberg interviews Martin Shkreli about the AI landscape and the challenges in biotech and pharma industries.
Erik Torenberg speaks with Martin Shkreli, American investor and businessman, about how he sees the AI landscape, from OpenAI to Anthropic, and what actually matters beyond the hype. They also talk through the future of computing, the limits of “vibe coding,” and why biotech and pharma remain some of the toughest industries to get right.
More episodes of The a16z Show
- Ben Horowitz on Venture Capital and AI
- AI Inside the Enterprise
- Balaji Srinivasan: Prove Correct, Not Just Go Direct
- Marc Andreessen: Monitoring the Situation and the Future of Media
- Rethinking Git for the Age of Coding Agents with GitHub Cofounder Scott Chacon
- Network Effects, AI Costs, and the Future of Consumer Investing with Anish Acharya on The Kevin Rose Show
Explore listener stats, chart rankings, contacts and more on the The a16z Show podcast page.